Immunotherapy for Gestational Trophoblastic Neoplasia: A New Paradigm.

Saved in:
Bibliographic Details
Title: Immunotherapy for Gestational Trophoblastic Neoplasia: A New Paradigm.
Authors: Baas IO; Department of Medical Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands, i.o.baas-3@umcutrecht.nl., Westermann AM; Department of Medical Oncology, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, The Netherlands., You B; Université Lyon 1, Hospices Civils De Lyon, Centre Français De Référence Des Maladies Trophoblastiques, Hôpital Lyon Sud, CITOHL, EA 3738 CICLY, Univ Lyon 1, Lyon, France., Bolze PA; Université Lyon 1, Hospices Civils De Lyon, Centre Français De Référence Des Maladies Trophoblastiques, Hôpital Lyon Sud, CITOHL, EA 3738 CICLY, Univ Lyon 1, Lyon, France., Seckl M; Department of Medical Oncology, Gestational Trophoblastic Disease Centre, Imperial College Healthcare NHS Trust, Charing Cross Hospital, London, UK., Ghorani E; Department of Medical Oncology, Gestational Trophoblastic Disease Centre, Imperial College Healthcare NHS Trust, Charing Cross Hospital, London, UK.
Source: Gynecologic and obstetric investigation [Gynecol Obstet Invest] 2024; Vol. 89 (3), pp. 230-238. Date of Electronic Publication: 2023 Sep 13.
Publication Type: Journal Article; Review
Journal Info: Publisher: Karger Country of Publication: Switzerland NLM ID: 7900587 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1423-002X (Electronic) Linking ISSN: 03787346 NLM ISO Abbreviation: Gynecol Obstet Invest Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1423-002X
DOI:10.1159/000533972